Last reviewed · How we verify
Type 2 collagen
At a glance
| Generic name | Type 2 collagen |
|---|---|
| Also known as | Mobithron Advance |
| Sponsor | TCI Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision (NA)
- Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. (PHASE2)
- Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators. (PHASE2)
- A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (PHASE3)
- Evaluation of D-Fi for the Treatment of Wounds Due to DEB (PHASE3)
- Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration Versus Early Implant Placement in the Esthetic Zone (NA)
- Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee (NA)
- Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Type 2 collagen CI brief — competitive landscape report
- Type 2 collagen updates RSS · CI watch RSS
- TCI Co., Ltd. portfolio CI